Powell's Cash Surge: Goldmine or Trap?

Powell, a company with $500 million in net cash, has shown impressive growth with 20.6% annual revenue growth and a 58.2% increase in earnings per share. Its free cash flow margin has also significantly improved, making it a promising investment at $252.76 per share and 42.7 times forward earnings. In contrast, 10x Genomics and Novavax, with their cash piles but lack of growth, present risks for investors. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/b26adab5347963bd